| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| B-Lymphocytes | 31 | 2023 | 703 | 4.980 |
Why?
|
| Lupus Nephritis | 13 | 2023 | 78 | 3.710 |
Why?
|
| Receptors, Antigen, B-Cell | 17 | 2022 | 103 | 3.490 |
Why?
|
| Germinal Center | 6 | 2023 | 62 | 2.280 |
Why?
|
| Precursor Cells, B-Lymphoid | 6 | 2023 | 27 | 1.940 |
Why?
|
| Immunity, Humoral | 5 | 2021 | 74 | 1.560 |
Why?
|
| Kidney | 9 | 2023 | 1093 | 1.420 |
Why?
|
| Lymphopoiesis | 6 | 2019 | 47 | 1.410 |
Why?
|
| Cyclin D3 | 7 | 2018 | 21 | 1.260 |
Why?
|
| Nephritis, Interstitial | 3 | 2016 | 44 | 1.250 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2019 | 60 | 1.170 |
Why?
|
| Signal Transduction | 13 | 2023 | 3497 | 1.140 |
Why?
|
| Chromatin | 5 | 2023 | 440 | 1.130 |
Why?
|
| Inflammation | 8 | 2022 | 1048 | 1.130 |
Why?
|
| Immunoglobulin Variable Region | 4 | 2018 | 87 | 1.070 |
Why?
|
| Carrier Proteins | 4 | 2018 | 660 | 1.060 |
Why?
|
| Immunoglobulins | 3 | 2015 | 122 | 1.030 |
Why?
|
| Mice | 36 | 2023 | 12226 | 0.940 |
Why?
|
| Endocytosis | 5 | 2017 | 184 | 0.910 |
Why?
|
| Animals | 46 | 2023 | 27968 | 0.900 |
Why?
|
| Autoantibodies | 5 | 2021 | 276 | 0.840 |
Why?
|
| Cell Differentiation | 11 | 2023 | 1610 | 0.780 |
Why?
|
| Endosomes | 4 | 2017 | 86 | 0.770 |
Why?
|
| Recombination, Genetic | 5 | 2022 | 420 | 0.760 |
Why?
|
| Adaptive Immunity | 4 | 2019 | 179 | 0.740 |
Why?
|
| Agammaglobulinemia | 2 | 2018 | 20 | 0.710 |
Why?
|
| CD79 Antigens | 5 | 2017 | 17 | 0.700 |
Why?
|
| Antigen Presentation | 5 | 2022 | 229 | 0.670 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 555 | 0.670 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 2022 | 171 | 0.650 |
Why?
|
| Allografts | 1 | 2021 | 205 | 0.640 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 31 | 0.620 |
Why?
|
| Pre-B Cell Receptors | 3 | 2019 | 8 | 0.620 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 220 | 0.610 |
Why?
|
| Receptors, Interleukin-7 | 4 | 2019 | 30 | 0.610 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2023 | 79 | 0.610 |
Why?
|
| Ubiquitination | 2 | 2017 | 78 | 0.590 |
Why?
|
| Receptors, CXCR4 | 1 | 2019 | 49 | 0.590 |
Why?
|
| Cell Cycle | 2 | 2012 | 515 | 0.590 |
Why?
|
| Dendritic Cells | 3 | 2022 | 536 | 0.590 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2019 | 17 | 0.580 |
Why?
|
| Gene Expression Regulation | 8 | 2023 | 1980 | 0.580 |
Why?
|
| Antigens, CD | 4 | 2002 | 476 | 0.580 |
Why?
|
| RNA Polymerase II | 1 | 2018 | 60 | 0.570 |
Why?
|
| STAT5 Transcription Factor | 4 | 2019 | 44 | 0.560 |
Why?
|
| Autoantigens | 2 | 2020 | 138 | 0.560 |
Why?
|
| Lymphocytes | 3 | 2016 | 453 | 0.540 |
Why?
|
| Kidney Failure, Chronic | 1 | 2022 | 430 | 0.540 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2017 | 13 | 0.540 |
Why?
|
| Graft Rejection | 2 | 2021 | 1123 | 0.530 |
Why?
|
| T-Lymphocytes | 4 | 2019 | 1275 | 0.520 |
Why?
|
| Machine Learning | 1 | 2020 | 346 | 0.510 |
Why?
|
| Kidney Transplantation | 2 | 2021 | 871 | 0.510 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2019 | 36 | 0.480 |
Why?
|
| Cell Proliferation | 5 | 2023 | 1732 | 0.460 |
Why?
|
| Cell Nucleus | 3 | 2019 | 601 | 0.450 |
Why?
|
| Histone Acetyltransferases | 1 | 2015 | 45 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2016 | 203 | 0.450 |
Why?
|
| Vimentin | 1 | 2014 | 47 | 0.430 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2023 | 149 | 0.430 |
Why?
|
| Mice, Knockout | 11 | 2020 | 2121 | 0.420 |
Why?
|
| Transcription, Genetic | 2 | 2018 | 1114 | 0.420 |
Why?
|
| Inflammasomes | 1 | 2014 | 31 | 0.410 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 740 | 0.410 |
Why?
|
| Apoptosis | 2 | 2016 | 1719 | 0.390 |
Why?
|
| Ubiquitin | 2 | 2017 | 95 | 0.380 |
Why?
|
| Humans | 32 | 2023 | 93130 | 0.370 |
Why?
|
| Kidney Diseases | 1 | 2014 | 309 | 0.340 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2020 | 66 | 0.340 |
Why?
|
| Interferon Regulatory Factors | 3 | 2022 | 75 | 0.330 |
Why?
|
| Phospholipids | 1 | 2011 | 106 | 0.330 |
Why?
|
| Phosphoproteins | 2 | 2002 | 258 | 0.330 |
Why?
|
| Cicatrix | 1 | 2011 | 74 | 0.330 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2011 | 166 | 0.320 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2015 | 24 | 0.320 |
Why?
|
| Adenosine Triphosphatases | 1 | 2011 | 140 | 0.320 |
Why?
|
| Kidney Tubules | 1 | 2010 | 91 | 0.320 |
Why?
|
| Cell Cycle Proteins | 2 | 2023 | 409 | 0.320 |
Why?
|
| Immunoglobulin G | 3 | 2021 | 465 | 0.320 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 606 | 0.310 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 281 | 0.310 |
Why?
|
| Palatine Tonsil | 2 | 2021 | 31 | 0.300 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2021 | 235 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2023 | 337 | 0.300 |
Why?
|
| Clonal Anergy | 1 | 2009 | 32 | 0.290 |
Why?
|
| ras Proteins | 1 | 2009 | 132 | 0.280 |
Why?
|
| Immunoglobulin Heavy Chains | 3 | 2020 | 106 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 6 | 2019 | 3427 | 0.260 |
Why?
|
| Gene Expression Profiling | 3 | 2020 | 1517 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 367 | 0.250 |
Why?
|
| Interleukin-7 | 3 | 2020 | 47 | 0.240 |
Why?
|
| Phosphorylation | 5 | 2020 | 1129 | 0.240 |
Why?
|
| Base Sequence | 5 | 2020 | 2207 | 0.240 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 2 | 2017 | 41 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2019 | 2827 | 0.210 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2006 | 304 | 0.210 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2021 | 1269 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2018 | 151 | 0.210 |
Why?
|
| Computational Biology | 2 | 2020 | 581 | 0.200 |
Why?
|
| Flow Cytometry | 3 | 2012 | 710 | 0.190 |
Why?
|
| STAT3 Transcription Factor | 1 | 2023 | 87 | 0.190 |
Why?
|
| DNA Damage | 2 | 2023 | 389 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2012 | 33 | 0.190 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 443 | 0.180 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 88 | 0.180 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2022 | 17 | 0.180 |
Why?
|
| V(D)J Recombination | 2 | 2018 | 12 | 0.170 |
Why?
|
| Gene Ontology | 1 | 2021 | 37 | 0.170 |
Why?
|
| Down-Regulation | 2 | 2015 | 523 | 0.170 |
Why?
|
| Immunohistochemistry | 2 | 2016 | 1786 | 0.170 |
Why?
|
| Clone Cells | 3 | 2023 | 219 | 0.170 |
Why?
|
| Adolescent | 4 | 2018 | 9550 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 30 | 0.170 |
Why?
|
| Cell Plasticity | 1 | 2021 | 13 | 0.170 |
Why?
|
| Transcriptional Activation | 2 | 2020 | 290 | 0.170 |
Why?
|
| Mammals | 1 | 2023 | 259 | 0.170 |
Why?
|
| Microscopy | 1 | 2021 | 88 | 0.170 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2021 | 37 | 0.170 |
Why?
|
| Immunoblotting | 2 | 2012 | 273 | 0.160 |
Why?
|
| Genome | 1 | 2023 | 407 | 0.160 |
Why?
|
| Protein Binding | 4 | 2020 | 1526 | 0.160 |
Why?
|
| Antibody Formation | 1 | 2021 | 169 | 0.160 |
Why?
|
| Organ Specificity | 1 | 2021 | 278 | 0.160 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 208 | 0.160 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2021 | 207 | 0.160 |
Why?
|
| Plasma Cells | 3 | 2023 | 84 | 0.150 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 481 | 0.150 |
Why?
|
| Chemokine CXCL12 | 1 | 2019 | 38 | 0.150 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 306 | 0.150 |
Why?
|
| Antigen-Antibody Complex | 2 | 2016 | 88 | 0.150 |
Why?
|
| Transcription Factors | 3 | 2022 | 1687 | 0.150 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2019 | 68 | 0.150 |
Why?
|
| Autoimmunity | 2 | 2023 | 191 | 0.150 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 200 | 0.150 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2011 | 179 | 0.150 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 1014 | 0.140 |
Why?
|
| Proteome | 1 | 2020 | 152 | 0.140 |
Why?
|
| Bcl-2-Like Protein 11 | 2 | 2016 | 25 | 0.140 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 83 | 0.140 |
Why?
|
| Spleen | 3 | 2009 | 372 | 0.140 |
Why?
|
| Proteomics | 1 | 2020 | 261 | 0.140 |
Why?
|
| Male | 7 | 2022 | 44353 | 0.140 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2017 | 16 | 0.130 |
Why?
|
| Cyclins | 2 | 2009 | 80 | 0.130 |
Why?
|
| Molecular Sequence Data | 3 | 2015 | 2889 | 0.130 |
Why?
|
| Receptors, Antigen | 1 | 2017 | 13 | 0.130 |
Why?
|
| Adenosine | 1 | 2020 | 274 | 0.130 |
Why?
|
| Cyclin D2 | 2 | 2013 | 18 | 0.130 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 393 | 0.130 |
Why?
|
| Mice, Inbred NZB | 1 | 2016 | 13 | 0.130 |
Why?
|
| Laser Capture Microdissection | 1 | 2016 | 20 | 0.130 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 102 | 0.130 |
Why?
|
| Sequence Analysis, RNA | 1 | 2018 | 257 | 0.120 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 556 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2016 | 41 | 0.120 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 1849 | 0.120 |
Why?
|
| Bone Marrow | 2 | 2019 | 408 | 0.120 |
Why?
|
| RNA | 1 | 2020 | 574 | 0.120 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2018 | 293 | 0.120 |
Why?
|
| Kidney Glomerulus | 1 | 2016 | 121 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 2 | 2016 | 888 | 0.120 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2016 | 98 | 0.120 |
Why?
|
| Methylation | 2 | 2020 | 288 | 0.120 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 317 | 0.120 |
Why?
|
| Young Adult | 3 | 2014 | 6922 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1099 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 1994 | 0.120 |
Why?
|
| Biopsy | 2 | 2021 | 1172 | 0.110 |
Why?
|
| Alleles | 1 | 2018 | 1139 | 0.110 |
Why?
|
| Immunoglobulin E | 1 | 2015 | 147 | 0.110 |
Why?
|
| Interferons | 1 | 2015 | 112 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2002 | 550 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2019 | 1581 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 435 | 0.110 |
Why?
|
| Genomic Instability | 1 | 2015 | 89 | 0.110 |
Why?
|
| Immunoprecipitation | 1 | 2014 | 136 | 0.110 |
Why?
|
| Adult | 4 | 2018 | 27849 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1385 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2015 | 1231 | 0.110 |
Why?
|
| Transcriptome | 1 | 2020 | 761 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 331 | 0.100 |
Why?
|
| Amino Acid Motifs | 2 | 2006 | 118 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-bcl-6 | 1 | 2014 | 42 | 0.100 |
Why?
|
| Genomics | 1 | 2020 | 848 | 0.100 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 187 | 0.100 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2014 | 26 | 0.100 |
Why?
|
| Child | 2 | 2018 | 7273 | 0.100 |
Why?
|
| Antibodies, Antinuclear | 2 | 2015 | 94 | 0.100 |
Why?
|
| Female | 6 | 2022 | 48540 | 0.100 |
Why?
|
| Interleukins | 1 | 2014 | 133 | 0.100 |
Why?
|
| Receptors, Platelet-Derived Growth Factor | 2 | 2006 | 17 | 0.100 |
Why?
|
| Biomarkers | 1 | 2020 | 1905 | 0.100 |
Why?
|
| Inflammation Mediators | 1 | 2014 | 159 | 0.100 |
Why?
|
| Trans-Activators | 2 | 2010 | 439 | 0.100 |
Why?
|
| Cell Communication | 1 | 2014 | 216 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2013 | 168 | 0.100 |
Why?
|
| Binding Sites | 2 | 2015 | 1126 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2015 | 727 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 281 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2012 | 17 | 0.090 |
Why?
|
| Microarray Analysis | 1 | 2012 | 95 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2008 | 663 | 0.090 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2012 | 58 | 0.090 |
Why?
|
| DNA Primers | 1 | 2012 | 528 | 0.090 |
Why?
|
| Binding, Competitive | 1 | 2011 | 136 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2015 | 556 | 0.090 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2011 | 32 | 0.090 |
Why?
|
| COS Cells | 1 | 2011 | 163 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2014 | 353 | 0.090 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2010 | 20 | 0.080 |
Why?
|
| Cluster Analysis | 1 | 2011 | 391 | 0.080 |
Why?
|
| Ikaros Transcription Factor | 1 | 2010 | 25 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1925 | 0.080 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2009 | 74 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2009 | 44 | 0.080 |
Why?
|
| Time Factors | 2 | 2009 | 5380 | 0.070 |
Why?
|
| Models, Molecular | 3 | 2002 | 1353 | 0.070 |
Why?
|
| Antibodies, Antiphospholipid | 1 | 2009 | 10 | 0.070 |
Why?
|
| Histones | 1 | 2011 | 361 | 0.070 |
Why?
|
| Mutation | 3 | 2011 | 4265 | 0.070 |
Why?
|
| United States | 1 | 2022 | 7581 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 891 | 0.070 |
Why?
|
| Antigens, Ly | 1 | 2009 | 36 | 0.070 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 123 | 0.070 |
Why?
|
| Tumor Cells, Cultured | 2 | 2002 | 1022 | 0.070 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2008 | 14 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2008 | 424 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 1910 | 0.070 |
Why?
|
| Gene Silencing | 1 | 2009 | 177 | 0.070 |
Why?
|
| Lymphoid Progenitor Cells | 1 | 2008 | 16 | 0.070 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2010 | 288 | 0.070 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2009 | 98 | 0.070 |
Why?
|
| Cell Line | 3 | 2015 | 2458 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 201 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 672 | 0.070 |
Why?
|
| Ligands | 1 | 2009 | 476 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 885 | 0.070 |
Why?
|
| Protein Transport | 1 | 2009 | 438 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2009 | 691 | 0.060 |
Why?
|
| Cell Movement | 1 | 2010 | 804 | 0.060 |
Why?
|
| Biological Transport | 1 | 2007 | 398 | 0.060 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 2006 | 3 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 1703 | 0.060 |
Why?
|
| Monophenol Monooxygenase | 1 | 2006 | 9 | 0.060 |
Why?
|
| Phospholipase C gamma | 2 | 2006 | 14 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-vav | 2 | 2006 | 10 | 0.060 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2007 | 183 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2006 | 144 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2006 | 244 | 0.060 |
Why?
|
| Cell Lineage | 2 | 2005 | 321 | 0.060 |
Why?
|
| Cell Survival | 2 | 2023 | 1002 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2011 | 3044 | 0.050 |
Why?
|
| Infant | 1 | 2010 | 3156 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3814 | 0.050 |
Why?
|
| CCCTC-Binding Factor | 1 | 2023 | 20 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2010 | 3781 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2006 | 661 | 0.050 |
Why?
|
| Actins | 1 | 2006 | 467 | 0.050 |
Why?
|
| Cell Division | 1 | 2004 | 689 | 0.050 |
Why?
|
| Syk Kinase | 1 | 2002 | 8 | 0.050 |
Why?
|
| Type C Phospholipases | 1 | 2002 | 26 | 0.050 |
Why?
|
| Enzyme Precursors | 1 | 2002 | 20 | 0.050 |
Why?
|
| GRB2 Adaptor Protein | 1 | 2002 | 10 | 0.050 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2002 | 27 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2002 | 28 | 0.050 |
Why?
|
| Immunoglobulin Constant Regions | 1 | 2002 | 11 | 0.050 |
Why?
|
| Phosphotyrosine | 1 | 2002 | 31 | 0.050 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2002 | 19 | 0.050 |
Why?
|
| src Homology Domains | 1 | 2002 | 45 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2008 | 1260 | 0.040 |
Why?
|
| Genes, Immunoglobulin | 1 | 2002 | 61 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2022 | 149 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2002 | 85 | 0.040 |
Why?
|
| Sodium | 1 | 2023 | 328 | 0.040 |
Why?
|
| Allergens | 1 | 2022 | 188 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2007 | 2757 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2022 | 218 | 0.040 |
Why?
|
| Immunologic Memory | 1 | 2022 | 184 | 0.040 |
Why?
|
| Lymphocyte Activation | 2 | 2019 | 798 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2022 | 271 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2002 | 271 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2002 | 302 | 0.040 |
Why?
|
| Cell Size | 1 | 2020 | 71 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 155 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 392 | 0.040 |
Why?
|
| Immunoglobulin Light Chains, Surrogate | 1 | 2019 | 4 | 0.040 |
Why?
|
| Myoglobin | 1 | 1999 | 28 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 2 | 2012 | 174 | 0.040 |
Why?
|
| Models, Biological | 1 | 2006 | 1768 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 161 | 0.040 |
Why?
|
| Methyltransferases | 1 | 2020 | 212 | 0.040 |
Why?
|
| Cytoplasm | 1 | 1999 | 275 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 9070 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 372 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 306 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 1999 | 468 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2017 | 108 | 0.030 |
Why?
|
| Proteins | 1 | 2002 | 790 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 106 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2545 | 0.030 |
Why?
|
| Lung | 1 | 2022 | 1359 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 660 | 0.030 |
Why?
|
| Phagosomes | 1 | 2015 | 40 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 287 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2015 | 111 | 0.030 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2015 | 64 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 958 | 0.030 |
Why?
|
| Hypoxia | 1 | 2020 | 672 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 1205 | 0.030 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 245 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2020 | 2020 | 0.030 |
Why?
|
| Tyrosine | 2 | 2006 | 131 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2012 | 35 | 0.020 |
Why?
|
| Retinoblastoma Protein | 1 | 2012 | 68 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 29 | 0.020 |
Why?
|
| Receptor, Notch1 | 1 | 2012 | 101 | 0.020 |
Why?
|
| PAX5 Transcription Factor | 1 | 2012 | 33 | 0.020 |
Why?
|
| Cytokines | 1 | 2015 | 862 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2010 | 67 | 0.020 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2008 | 21 | 0.020 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 2008 | 18 | 0.020 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 79 | 0.020 |
Why?
|
| Cell Death | 1 | 2008 | 252 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2008 | 364 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 217 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 453 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 630 | 0.010 |
Why?
|
| Immunoglobulin Joining Region | 1 | 2002 | 8 | 0.010 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Light Chain | 1 | 2002 | 15 | 0.010 |
Why?
|
| Valine | 1 | 2002 | 46 | 0.010 |
Why?
|
| Lymphocyte Count | 1 | 2002 | 98 | 0.010 |
Why?
|
| Gene Targeting | 1 | 2002 | 72 | 0.010 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2002 | 63 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2002 | 88 | 0.010 |
Why?
|
| Glycine | 1 | 2002 | 93 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 1173 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2002 | 268 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 237 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 2002 | 264 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 726 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 1999 | 165 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 1999 | 138 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1999 | 319 | 0.010 |
Why?
|